Top Biotechnology companies in Australia by Total Assets

This ranking features the top 13 Biotechnology companies in Australia ranked by Total Assets, totaling a Total Assets of USD 40.47 B, for June 29, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Australia has the highest Total Assets ?

The Biotechnology company in Australia with the highest Total Assets is CSL Limited (ASX: CSL.AX) at USD 38.02 B.
Which Biotechnology company in Australia has the lowest Total Assets ?

The Biotechnology company in Australia with the lowest Total Assets is PYC Therapeutics Limited (ASX: PYC.AX) at None.

What are the top 10 Biotechnology companies in Australia by Total Assets ?

The top 10 Biotechnology companies in Australia by Total Assets are CSL Limited, Telix Pharmaceuticals Limited, Mesoblast Limited, Australian Clinical Labs Limited, Clinuvel Pharmaceuticals Limited, Immutep Limited, Anteris Technologies Ltd, PolyNovo Limited, Alterity Therapeutics Limited and Clarity Pharmaceuticals Ltd.
What are the bottom 10 Biotechnology companies in Australia by Total Assets ?

The bottom 10 Biotechnology companies in Australia by Total Assets are PYC Therapeutics Limited, Kazia Therapeutics Limited, Immuron Limited, Clarity Pharmaceuticals Ltd, Alterity Therapeutics Limited, PolyNovo Limited, Anteris Technologies Ltd, Immutep Limited, Clinuvel Pharmaceuticals Limited and Australian Clinical Labs Limited.